Clinical Trial Update: Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial in melanoma evaluating immune checkpoint blockade in combination with a prebiotic dietary intervention (NEO-PreFED) to optimize anti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 2 | Status: RECRUITING